Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tecfidera in Radiologically Isolated Syndrome (ARISE)
NCT02739542Phase 4Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Mar 2016
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dimethyl fumarate in radiologically isolated syndrome (RIS), sponsored by UT Southwestern Medical Center. Primary endpoint: Time From Randomization to the First Demyelinating Event at 96 weeks. Started Mar 2016; status: completed.
02
Drugs
dimethyl fumarate
03
Conditions
radiologically isolated syndrome (RIS)
Beyond the preview
Go deeper on NCT02739542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02739542.